Here are relevant reports on : atp-assay-market
-
miRNA Sequencing and Assay Market by Product (Library Preparation, Consumables), Technology (Sequencing By Synthesis, Nanopore, Ion Semiconductor Sequencing), End User (Research Institute, Academia, CRO), Region - Global Forecast To 2024
The miRNA sequencing and assays market is projected to reach USD 343 million by 2024, at a CAGR of 11.2%. Growth in this market is driven by factors such as the advantages of miRNA sequencing over other technologies, increasing research funding for genomics, and the decreasing cost of sequencing.Illumina (US), Thermo Fisher Scientific (US), QIAGEN (Germany), Takara Bio (Japan), NEB (UK), and 5 others.
- Published: March 2019
- Price: $ 4950
- TOC Available:
-
IVD Contract Manufacturing Market by Device Type (Consumables, Equipment), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation), Service (Manufacturing, Assay Development) - Global Forecast to 2028
The global IVD contract manufacturing market, valued at US$14.2 billion in 2022, stood at US$15.4 billion in 2023 and is projected to advance at a resilient CAGR of 11.5% from 2023 to 2028, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth in this market can primarily be attributed to the growing need for less costly and better equipment's, increased need for IVD OEMs to establish themselves in the high potential market and emerge as a budding player in other allied markets, reduced risk of development failure, and reduction in cross contamination of IVD consumables at the CMO facility, and emergence of small scaled outsourcing facilities in emerging nations.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
C – Reactive Protein Testing Market by Assay Type (ELISA, Turbidimetric, Immunoturbidimetric), Application (Cardiovascular, Inflammatory Disease, Rheumatoid Arthritis, Cancer), End User (Hospitals, Clinics, Diagnostics Labs) - Global Forecast to 2023
The Global C-Reactive Protein Testing market is expected to reach USD 1.75 billion by 2023 from USD 1.62 billion in 2018, growing at a CAGR of 1.5 % from 2018 to 2023. Growing occurrences of Non Communicable Diseases (NCDs) such as Cardiovascular Diseases, Diabetes and other inflammatory diseases are the major drivers for this market. Point of Care technology for CRP testing is also being used for diagnostic purposes.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
EliSpot and FluoroSpot Assay Market by Product (Assay kit (Technique, Utility, Analyte (T Cell and B Cell assay)), Analyzer), Application (Transplants, Infectious Diseases, Vaccine Development, Cancer Research), End User & Region - Global Forecast to 2028
The global EliSpot and FluoroSpot assay market, valued at US$272 million in 2022, stood at US$292 million in 2023 and is projected to advance at a resilient CAGR of 7.6% from 2023 to 2028, culminating in a forecasted valuation of US$421 million by the end of the period. The expansion of this market is majorly due to up surging cases of chronic diseases such as cancer as well as growing Growth in biotechnology and biopharmaceutical industries.
- Published: November 2023
- Price: $ 4950
- TOC Available:
-
Over The Counter/OTC Test Market by Product (Glucose Monitoring Test, Cholesterol Monitoring Test, Infectious Disease Testing, Fecal Occult Test, Urine Analysis Test, Drug Abuse Test), Technology (Immunoassay, Lateral Flow Assay)-Global Forecast to 2024
The Over The Counter Test Market is projected to reach USD 22.2 billion by 2024, at CAGR of 11.0%. The growth of the OTC tests market is mainly driven by the rising prevalence of target diseases and disorders, such as diabetes and infectious diseases, both prominent ailments across the globe that require rapid and effective testing.OraSure Technologies (US), Roche Diagnostics (Switzerland), and i-Health Lab (US).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Isothermal Nucleic Acid Amplification Technology Market by Product (Assay, System), Technology (LAMP, SDA, NASBA, NEAR, HDA), Application (Diagnostics (Influenza, Hepatitis, CT/NG, COVID-19), blood screening), End User & Region - Global Forecast to 2028
The global isothermal nucleic acid amplification technology market, stood at US$4.4 billion in 2023 and is projected to advance at a resilient CAGR of 9.2% from 2023 to 2028, culminating in a forecasted valuation of US$6.8 billion by the end of the period. The growth of the market is attributed to the cost-benefits of INAAT, rising prevalence of infectious diseases, and increasing number of blood transfusions and donations.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Blood Group Typing Market by Product (Consumables, Instruments, Services), Test Type (ABO, Antigen, Antibody, HLA), Technique (Assay-based, PCR, Microarray, Massively Parallel Sequencing), End User (Hospital, Blood Banks), Region - Global Forecast to 2028
The global blood group typing market, valued at US$1.8billion in 2022, stood at US$2.0 billion in 2023 and is projected to advance at a resilient CAGR of 8.7% from 2023 to 2028, culminating in a forecasted valuation of US$3.0 billion by the end of the period. The increasing frequency of road accidents contributes to the expansion of the market.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Creatinine Assay Kits Market by Type (Jaffe's Kinetic Test, Creatinine-PAP, and ELISA), Sample (Blood, Serum, Urine, Saliva, CSF, Tissue Homogenate, Sweat) and Region (North America, Europe, Asia and RoW) - Global Forecast to 2022
The global creatinine assay kits market is expected to reach USD 245.4 Million by 2022 from USD 189.6 Million in 2017, at a CAGR of 5.3%. The growth of this market is mainly driven by the increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, growing awareness and adoption of preventive healthcare, favourable government initiatives to promote renal health, rapid growth in the geriatric population, and advancements in biomedical research pertaining to kidney disorders and availability of funding. The creatinine assay kits market is highly fragmented with the presence of several large as well as emerging players. Prominent players in this market include Thermo Fisher Scientific (US), Merck (Germany), Abbott Laboratories (US), Abcam (UK), Quidel (US), Enzo Life Sciences (US), Cayman Chemical (US), Crystal Chem (US), Cell Biolabs (US), Genway Biotech (US), BioAssay Systems (US), Wako Pure Chemical Industries (Japan), Tulip Diagnostics (India), BioVision (US), and Arbor Assays (US).
- Published: March 2018
- Price: $ 14000
- TOC Available:
-
Breast Biopsy Devices Market by Product (Needle: Core, FNAB, VAB; Equipment, Wire, Guidance system, Table, Assay kit), Procedure (Needle, Liquid: CTC, CTDNA; Open), Application (Screening, Monitoring), End User (Hospital, Clinic) - Global Forecasts to 2030
The global breast biopsy devices market, valued at US$2,255.0 million in 2024, stood at US$2,384.1 million in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$3,261.7 million by the end of the period. The breast biopsy devices market is driven by rising breast cancer incidence, growing awareness, technological advancements, and increased demand for minimally invasive procedures.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Newborn Screening Market by Product (Instrument, Consumables), Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Molecular, Pulse Oximetry), End User (Hospitals) & Region - Global Forecast to 2026
The global newborn screening market growth is primed to transition from $0.9 billion in 2021 to $1.3 billion by 2026, showcasing a strong CAGR of 8.3%. Growth in this market is primarily driven by the increasing prevalence of newborn disorders and favourable reimbursement policies. However, the availability of refurbished products is expected to restrain the growth of this market to a certain extent during the forecast period.
- Published: February 2021
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
